GO:0004113 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004113 describes the enzymatic activity that hydrolyzes a nucleoside 2',3'-cyclic phosphate to a nucleoside 2'-phosphate, a reaction classically associated with CNPase (CNP) in myelin.
• CNP is one of the most abundant myelin proteins and is widely used as a marker of oligodendrocytes and myelin, but its catalytic activity is only one facet of a multifunctional protein.
• The active site of CNP binds 2',3'-cyclic nucleotide ligands, and structural studies have defined key residues and conformational changes linked to catalysis.
• Beyond myelin, CNP has been reported to bind RNA and inhibit protein synthesis, and CNP1 functional isoforms have been implicated in antagonizing HIV-1 particle assembly.
• CNP activity has been linked to mitochondrial permeability transition pore regulation and to CNS degeneration paradigms, making it relevant to neurodegeneration research.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of CNP/CNPase-related functions in oligodendrocyte biology and disease.
Description
GO:0004113, 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity, is a molecular function defined by the hydrolysis of a nucleoside 2',3'-cyclic phosphate to a nucleoside 2'-phosphate. This activity is historically associated with CNPase (CNP), a protein enriched in myelin and long used as a marker of oligodendrocytes and Schwann cells. Researchers study this term because it sits at the intersection of myelin biology, RNA metabolism, mitochondrial regulation, and host-pathogen interactions. The catalytic reaction itself is chemically simple, but the protein context is complex: CNP is multifunctional, and its enzymatic activity must be interpreted alongside its structural and RNA-binding properties. In model systems, CNP has been connected to oligodendrocyte differentiation and mitochondrial remodeling, and CNP1 isoforms have been reported to influence HIV-1 particle assembly. Because the term is a molecular_function, the most informative experiments combine enzymatic assays with genetic perturbation and cell-biological readouts. This article summarizes the QuickGO definition, the catalytic and structural mechanism, key genes, disease links, and the CRISPR and multi-omics methods used to study GO:0004113.
2',3'-cyclic-nucleotide 3'-phosphodiesterase activity At A Glance
| GO ID | GO:0004113 |
|---|---|
| GO term | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity |
| Ontology | molecular_function |
| Definition | Catalysis of the reaction: nucleoside 2',3'-cyclic phosphate + H2O = nucleoside 2'-phosphate |
| Synonyms | 2':3'-CNMP-3'-ase activity; 2',3'-cyclic AMP phosphodiesterase activity; 2',3'-cyclic nucleoside monophosphate phosphodiesterase; 2',3'-cyclic nucleotide 3'-phosphodiesterase activity; 2':3'-cyclic nucleotide 3'-phosphodiesterase activity; 2',3'-cyclic nucleotide 3'-phosphohydrolase activity; 2',3'-cyclic nucleotide phosphohydrolase; CNPase activity; cyclic 2',3'-nucleotide 3'-phosphodiesterase activity; cyclic 2',3'-nucleotide phosphodiesterase; cyclic-CMP phosphodiesterase activity; nucleoside-2',3'-cyclic-phosphate 2'-nucleotidohydrolase activity |
| Major function | Hydrolysis of nucleoside 2',3'-cyclic phosphates to nucleoside 2'-phosphates; classically measured as CNPase activity in myelin-rich tissues |
| Representative enzyme | CNP (2',3'-cyclic nucleotide 3'-phosphodiesterase), including CNP1 and CNP2 isoforms |
| Subcellular context | Enriched in myelin and myelin-like membranes; also reported in mitochondrial and RNA-associated contexts |
| Research relevance | Marker of oligodendrocytes and myelin; linked to CNS degeneration, mitochondrial regulation, RNA metabolism, and HIV-1 biology |
What Is GO:0004113?
In plain terms, GO:0004113 is the activity of an enzyme that removes a cyclic phosphate group from a nucleoside 2',3'-cyclic phosphate, producing a nucleoside 2'-phosphate and water-derived products. The QuickGO definition states: Catalysis of the reaction: nucleoside 2',3'-cyclic phosphate + H2O = nucleoside 2'-phosphate. The activity is also known as CNPase activity, 2',3'-cyclic nucleotide 3'-phosphohydrolase activity, and cyclic 2',3'-nucleotide 3'-phosphodiesterase activity. It is a molecular_function term, meaning it describes what an enzyme does at the reaction level rather than a whole pathway or cellular location. The best-characterized enzyme carrying this activity is CNP (2',3'-cyclic nucleotide 3'-phosphodiesterase), a myelin-associated protein whose active site has been studied with ligand binding and structural approaches.
Why Is 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity Important in Cell Biology?
GO:0004113 matters because it provides a defined biochemical handle on CNP, a protein that is both a classical myelin marker and a multifunctional regulator. Measuring this activity helps researchers assess oligodendrocyte and myelin status, and genetic or pharmacological perturbation of CNP can reveal roles beyond catalysis, including RNA binding, protein synthesis inhibition, and mitochondrial effects. The term is also important for comparative and evolutionary studies, since CNPase-like enzymes occur across taxa, including plants. In disease research, CNP activity has been discussed in the context of CNS degeneration and organometallic inhibition, and CNP1 isoforms have been linked to HIV-1 particle assembly. For CRISPR researchers, GO:0004113 offers a clear enzymatic readout to connect genotype to function in knockout, point-mutation, knock-in, and overexpression models.
• Provides a biochemical readout for CNP/CNPase function in myelin and oligodendrocyte biology.
• CNP is a widely used marker of oligodendrocytes and myelin, making the activity relevant to developmental and regenerative studies.
• Links to mitochondrial remodeling during oligodendrocyte differentiation, connecting the activity to organelle dynamics.
• Implicated in regulation of the mitochondrial permeability transition pore through phosphorylation-dependent mechanisms.
• CNP has RNA-binding capacity and can inhibit protein synthesis, expanding its functional repertoire beyond catalysis.
• CNP1 functional isoforms have been reported to antagonize HIV-1 particle assembly, linking the term to host-pathogen interactions.
• Organometallic vanadium complexes can inhibit CNPase, providing chemical tools to study CNS degeneration.
• Evolutionary studies show CNPase-like activities in non-mammalian systems such as wheat germ, supporting comparative biochemistry.
• Structural and ligand-binding studies of CNP provide a framework for understanding active-site mutations.
• The activity is a tractable endpoint for CRISPR-based causal tests of CNP gene function.
Molecular Mechanism of 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity
Substrate recognition and binding
In simple terms: The enzyme first grabs the cyclic nucleotide substrate in its active site.
CNP binds 2',3'-cyclic nucleotide ligands in its active site, and structural work has characterized the ligand-bound conformation of the myelin enzyme. This binding step positions the cyclic phosphate for subsequent hydrolysis. The active site architecture is conserved enough that CNPase-like activity can be detected across distant organisms, including wheat germ. In experimental terms, ligand binding is the basis for assays that monitor CNPase activity and for interpreting point mutations in the catalytic pocket.
Catalytic hydrolysis of the cyclic phosphate
In simple terms: The enzyme cuts the cyclic phosphate ring, leaving a 2'-phosphate on the nucleotide.
The defining reaction of GO:0004113 is the hydrolysis of a nucleoside 2',3'-cyclic phosphate to a nucleoside 2'-phosphate. This is a phosphodiesterase-type cleavage that converts a cyclic phosphodiester into a monoester product. The reaction is the canonical assay for CNPase activity and is used to monitor enzyme purification and function, as shown for wheat germ CNPase. In mammalian systems, the same activity is classically measured in myelin-rich fractions and is associated with CNP.
Conformational changes and active-site dynamics
In simple terms: The protein changes shape during catalysis, which helps it perform the reaction.
Structural and functional studies indicate that CNP undergoes conformational changes linked to active-site ligand binding. These dynamics are relevant because CNP is not a rigid enzyme; its conformation can influence substrate access and product release. The evolutionary conservation of CNPase domains further supports the idea that core structural features are important for activity. Researchers can probe these features using mutagenesis guided by the ligand-bound structure.
Regulation by phosphorylation and cellular context
In simple terms: Other signals in the cell can tune how active the enzyme is.
CNP function has been connected to protein phosphorylation-mediated regulation of the mitochondrial permeability transition pore, indicating that the activity does not operate in isolation. This places GO:0004113 within signaling networks that respond to cellular stress. In addition, CNP can bind RNA and inhibit protein synthesis, suggesting that its functional state depends on interacting partners and localization. Such context-dependent regulation is important when interpreting enzymatic assays in cell models.
Non-catalytic and moonlighting functions
In simple terms: The protein can do other jobs besides cutting cyclic nucleotides.
CNP is multifunctional: beyond its phosphodiesterase activity, it has been described as an RNA-binding protein that inhibits protein synthesis. CNP1 functional isoforms have also been reported to antagonize HIV-1 particle assembly, a function that may not require the canonical catalytic reaction. These moonlighting roles mean that knockout or point-mutation experiments must distinguish catalytic from non-catalytic contributions. This is a key reason why GO:0004113 is studied alongside protein-interaction and RNA-binding assays.
Key Genes Involved in GO:0004113 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity
The genes and proteins below are the principal factors experimentally linked to GO:0004113, its regulation, or its cellular context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CNP | Encodes 2',3'-cyclic nucleotide 3'-phosphodiesterase; carries the catalytic activity of GO:0004113 | Central enzyme for CNPase assays, myelin biology, and CRISPR perturbation |
| CNP1 | Functional isoform of CNP implicated in HIV-1 particle assembly antagonism | Isoform-specific knockout and overexpression studies |
| CNP2 | CNP isoform generated from the CNP gene; contributes to myelin-associated CNP pool | Isoform resolution in knock-in and tagged models |
| BNIP3L | Mitophagy receptor required for mitochondrial remodeling during optic nerve oligodendrocyte differentiation | Links CNP-related oligodendrocyte biology to mitochondrial quality control |
| MPTP-associated proteins | Components of the mitochondrial permeability transition pore whose regulation involves CNP | Studies of phosphorylation-dependent pore regulation |
| Ribosome-associated factors | Protein synthesis machinery affected by CNP RNA-binding and translation inhibition | Ribo-seq and polysome profiling after CNP perturbation |
| HIV-1 Gag | Viral structural protein whose assembly is antagonized by CNP1 functional isoform | Host-pathogen assays with CNP1 knockout/overexpression |
| Myelin basic protein (MBP) | Major myelin component co-enriched with CNP in myelin membranes | Myelin marker co-staining and oligodendrocyte differentiation studies |
| Proteolipid protein (PLP) | Myelin structural protein used alongside CNP as a myelin marker | Co-localization and myelin integrity assays |
| Oligodendrocyte lineage transcription factors | Regulate differentiation programs in which CNP is expressed | Differentiation time-course with CNP readouts |
| Wheat germ CNPase | Plant enzyme with 2',3'-cyclic nucleotide 3'-phosphodiesterase activity | Comparative biochemistry and purification studies |
| Vanadium complex targets | Organometallic inhibitors of CNPase | Chemical biology of CNS degeneration |
| Mitochondrial dynamics regulators | Proteins controlling fusion/fission during oligodendrocyte differentiation | Imaging and mitophagy assays in CNP-related models |
| RNA-binding proteins | Partners that may cooperate with CNP in RNA metabolism | RNA immunoprecipitation and interactome studies |
| Stress-response kinases | Kinases that phosphorylate targets affecting CNP-linked MPTP regulation | Phosphoproteomics and inhibitor studies |
How Is 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity Regulated?
GO:0004113 is regulated at multiple levels. At the protein level, CNP function has been linked to protein phosphorylation-mediated regulation of the mitochondrial permeability transition pore, indicating that kinase/phosphatase signaling can influence CNP-associated activities. At the RNA level, CNP behaves as an RNA-binding protein that inhibits protein synthesis, so its availability and interactions with RNA can shape its functional output. At the isoform level, CNP1 functional isoforms have been reported to antagonize HIV-1 particle assembly, suggesting isoform-specific regulation in host-pathogen contexts. At the cellular level, CNP expression and myelin association are tied to oligodendrocyte differentiation programs, and mitochondrial remodeling during differentiation involves BNIP3L-mediated mitophagy. Together, these layers mean that enzymatic activity measurements should be interpreted with attention to isoform usage, phosphorylation state, and cellular context.
2',3'-cyclic-nucleotide 3'-phosphodiesterase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CNP | CNS degeneration and myelin pathology | CNP knockout oligodendrocyte cultures and myelin marker assays |
| CNP | Mitochondrial permeability transition and cell stress | CNP point-mutation models with mitochondrial function readouts |
| CNP1 | HIV-1 particle assembly antagonism | CNP1 knockout and overexpression in viral assembly assays |
| CNP | RNA metabolism and translation inhibition | CNP knockout with Ribo-seq and polysome profiling |
| BNIP3L | Mitochondrial remodeling during oligodendrocyte differentiation | BNIP3L/CNP co-perturbation in differentiation models |
CNS degeneration and myelin pathology
CNP is a myelin-associated enzyme, and its activity is classically used as a marker of myelin and oligodendrocytes. Organometallic vanadium complexes have been studied as CNPase inhibitors, and this inhibition has been proposed as a potential paradigm for studying CNS degeneration. Because myelin integrity is central to neurological function, changes in GO:0004113 activity can accompany demyelinating or degenerative processes. Experimental models that perturb CNP can help determine whether altered activity is a cause or consequence of pathology.
Mitochondrial dysfunction and permeability transition
CNP has been implicated in the protein phosphorylation-mediated regulation of the mitochondrial permeability transition pore, a key event in cell death and mitochondrial dysfunction. Mitochondrial remodeling during oligodendrocyte differentiation requires BNIP3L-mediated mitophagy, connecting CNP-related biology to mitochondrial quality control. These findings suggest that GO:0004113 may intersect with pathways that decide cell survival under stress. Researchers can test this by combining CNP perturbation with mitochondrial function assays.
Host-pathogen interactions: HIV-1
The CNP1 functional isoform has been reported to antagonize HIV-1 particle assembly, linking CNP biology to viral replication. This function may be separable from the canonical phosphodiesterase reaction, making it important to distinguish catalytic and non-catalytic roles. Knockout and overexpression models can clarify which CNP domains are required for the antiviral effect. This area illustrates how a GO molecular_function term can be connected to infectious disease research.
RNA metabolism and translation control
CNP has been described as a novel RNA-binding protein that inhibits protein synthesis, expanding its disease relevance to translation control. Dysregulated translation is a feature of many neurological and proliferative disorders, so CNP's RNA-binding function may matter beyond myelin. Combining CNP perturbation with Ribo-seq or polysome profiling can reveal whether GO:0004113-associated proteins influence translation globally or selectively. This is an emerging area where mechanistic studies are still needed.
From 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is CNP catalytic activity required for oligodendrocyte differentiation? | CNP knockout and catalytically dead point-mutation knock-in |
| Which CNP isoform mediates anti-HIV-1 activity? | CNP1-specific knockout and isoform-specific overexpression |
| Does CNP active-site mutation alter ligand binding? | Point-mutation knock-in guided by ligand-bound structure |
| Where is CNP localized in myelin and mitochondria? | Tagged knock-in with fluorescent or epitope tag |
| Does CNP overexpression alter translation? | Inducible CNP overexpression with Ribo-seq |
| Can CNPase inhibition model CNS degeneration? | Chemical inhibition with vanadium complexes in neuronal/glial cultures |
How to Study the 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CNPase activity assay | Hydrolysis of 2',3'-cyclic nucleotide to 2'-nucleotide | Enzyme purification and inhibitor testing |
| Ligand-binding assay | Active-site substrate/ligand interaction | Point-mutation validation |
| Structural analysis | Molecular conformation of CNP | Active-site mapping and mutant design |
| RNA immunoprecipitation | RNA species bound by CNP | RNA-binding function studies |
| Ribo-seq / polysome profiling | Translation efficiency | Testing CNP effects on protein synthesis |
| Mitochondrial function assays | Permeability transition and respiration | Linking CNP to mitochondrial regulation |
| Live-cell imaging | Mitochondrial and myelin dynamics | Oligodendrocyte differentiation studies |
| Co-immunostaining | CNP co-localization with myelin markers | Myelin and oligodendrocyte characterization |
Enzymatic activity assays for CNPase
The most direct way to study GO:0004113 is to measure the conversion of nucleoside 2',3'-cyclic phosphate to nucleoside 2'-phosphate. Classical purification and characterization of CNPase from wheat germ provides a template for such assays. In mammalian samples, CNPase activity is measured in myelin-rich fractions and used as a biochemical marker. These assays can be combined with inhibitors such as organometallic vanadium complexes to probe active-site requirements.
Structural and ligand-binding approaches
Structural studies of myelin CNP have defined active-site ligand binding and molecular conformation, which helps interpret mutations. Ligand-binding assays can test whether point mutations in the catalytic pocket alter substrate engagement. Evolutionary comparisons of CNPase domains provide additional context for conserved residues. Together, these methods connect sequence to catalytic function.
RNA-binding and translation assays
Because CNP can bind RNA and inhibit protein synthesis, RNA-centric methods are valuable. RNA immunoprecipitation can identify associated transcripts, while polysome profiling or Ribo-seq can measure translation effects. These approaches help separate catalytic from non-catalytic functions of CNP. They are especially useful when CNP is overexpressed or knocked out.
Mitochondrial and imaging readouts
CNP has been linked to mitochondrial permeability transition pore regulation and to mitochondrial remodeling during oligodendrocyte differentiation. Mitochondrial function assays and live imaging can test whether CNP perturbation alters organelle dynamics. Co-staining with myelin markers such as MBP or PLP helps place CNP in cellular context. These readouts complement enzymatic assays.
How CRISPR Can Be Used to Study GO:0004113 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity
Knockout
CRISPR knockout of CNP or CNP1 can test whether GO:0004113 activity is required for oligodendrocyte differentiation, myelin maintenance, or antiviral functions. Knockout models are also useful to separate catalytic from non-catalytic roles when combined with activity assays. In mitochondrial studies, CNP knockout can be paired with BNIP3L perturbation to probe mitophagy-linked phenotypes. These experiments provide causal evidence that complements correlative expression data.
Point Mutation
Point-mutation knock-in of catalytic residues identified from ligand-bound structures can abolish phosphodiesterase activity while preserving protein expression. Such models are essential to determine whether a phenotype depends on catalysis or on protein scaffolding. Catalytically dead CNP mutants can be compared with knockouts in translation and mitochondrial assays. This approach directly interrogates the molecular_function defined by GO:0004113.
Knock-in
Tagged knock-in of CNP allows visualization and purification of the endogenous protein without overexpression artifacts. Knock-in of isoform-specific tags can distinguish CNP1 and CNP2 localization and interactions. These models support imaging of myelin and mitochondrial compartments. They also enable proteomic identification of CNP-associated complexes.
Overexpression
Overexpression of CNP or CNP1 can test gain-of-function effects on translation, viral assembly, and mitochondrial regulation. Inducible overexpression systems allow time-controlled experiments that avoid chronic adaptation. Overexpression combined with activity assays can reveal whether increased enzyme levels saturate or alter pathway output. These models are particularly useful for host-pathogen studies.
How EDITGENE Supports 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity Research
Researchers studying 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity-related genes often need to determine whether a candidate gene is causally involved in a phenotype or merely correlated with it. The most rigorous way to answer this is to build isogenic cell models in which the gene or its catalytic residue is precisely altered, then measure enzymatic, transcriptional, translational, and mitochondrial readouts. EDITGENE provides the CRISPR tools and cell-model engineering services to generate such models reproducibly.
Contact EDITGENE today to design your custom CRISPR model for 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity research.
Frequently Asked Questions About 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity
What is 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity?
It is the enzymatic activity defined by GO:0004113 that hydrolyzes a nucleoside 2',3'-cyclic phosphate to a nucleoside 2'-phosphate, classically measured as CNPase activity.
What is the GO ID for 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity?
The GO ID is GO:0004113, a molecular_function term in the Gene Ontology.
What genes are involved in 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity?
The principal gene is CNP, which encodes CNPase and its isoforms CNP1 and CNP2; related factors include BNIP3L and mitochondrial permeability transition pore components.
What reaction does GO:0004113 catalyze?
It catalyzes the reaction nucleoside 2',3'-cyclic phosphate + H2O = nucleoside 2'-phosphate.
Why is CNP used as a myelin marker?
CNP is highly enriched in myelin and oligodendrocytes, and its activity is a classical biochemical marker of myelin.
Does CNP have functions beyond its enzymatic activity?
Yes, CNP has been described as an RNA-binding protein that inhibits protein synthesis, and CNP1 isoforms can antagonize HIV-1 particle assembly.
How is CNPase activity measured in the lab?
It is measured by monitoring the conversion of 2',3'-cyclic nucleotides to 2'-nucleotides, often in myelin-rich fractions or purified enzyme preparations.
Is CNP involved in mitochondrial function?
CNP has been implicated in protein phosphorylation-mediated regulation of the mitochondrial permeability transition pore, and mitochondrial remodeling during oligodendrocyte differentiation involves BNIP3L-mediated mitophagy.
Can CNPase be inhibited chemically?
Organometallic vanadium complexes have been studied as CNPase inhibitors and proposed as tools for studying CNS degeneration.
How can CRISPR help study GO:0004113?
CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal tests of whether CNP catalytic activity or its other functions drive phenotypes.
Conclusion
GO:0004113, 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity, is a well-defined molecular function carried by CNP, a myelin-enriched and multifunctional protein. Its study spans myelin biology, mitochondrial regulation, RNA metabolism, and host-pathogen interactions, with experimental evidence linking CNP to oligodendrocyte differentiation, permeability transition pore regulation, translation inhibition, and HIV-1 assembly. Because CNP has both catalytic and non-catalytic roles, precise genetic models are essential to determine which functions depend on the phosphodiesterase reaction. CRISPR-based knockout, point-mutation, knock-in, and overexpression approaches, combined with enzymatic, structural, and multi-omics readouts, provide the most rigorous path forward for researchers investigating this term.
References
- 1. Yazdankhah M et al.. 2021. BNIP3L-mediated mitophagy is required for mitochondrial remodeling during the differentiation of optic nerve oligodendrocytes.. Autophagy 17(10):3140-3159 PMID: 33404293
- 2. Liang S et al.. 2024. 2',3' cyclic nucleotide 3' phosphodiesterase 1 functional isoform antagonizes HIV-1 particle assembly.. Life Sci Alliance 7(3) PMID: 38167610
- 3. Myllykoski M et al.. 2016. Structural and functional evolution of 2',3'-cyclic nucleotide 3'-phosphodiesterase.. Brain Res 1641(Pt A):64-78 PMID: 26367445
- 4. Tyc K et al.. 1987. Purification and characterization of wheat germ 2',3'-cyclic nucleotide 3'-phosphodiesterase.. J Biol Chem 262(27):12994-3000 PMID: 3654600
- 5. Platt DC et al.. 2021. 2'-3'-Cyclic Nucleotide 3'-Phosphodiesterase Inhibition by Organometallic Vanadium Complexes: A Potential New Paradigm for Studying CNS Degeneration.. Brain Sci 11(5) PMID: 33946593
- 6. Baburina Y et al.. 2018. Possible Involvement of 2',3'-Cyclic Nucleotide-3'-Phosphodiesterase in the Protein Phosphorylation-Mediated Regulation of the Permeability Transition Pore.. Int J Mol Sci 19(11) PMID: 30405014
- 7. Gravel M et al.. 2009. 2',3'-Cyclic nucleotide 3'-phosphodiesterase: a novel RNA-binding protein that inhibits protein synthesis.. J Neurosci Res 87(5):1069-79 PMID: 19021295
- 8. Myllykoski M et al.. 2012. Myelin 2',3'-cyclic nucleotide 3'-phosphodiesterase: active-site ligand binding and molecular conformation.. PLoS One 7(2):e32336 PMID: 22393399
